These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7383465)

  • 21. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
    Ekman G; Forman A; Ulmsten U; Wingerup L
    Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins for the management of anencephalic pregnancy.
    Thiery M; Parewijck W; Decoster JM
    Prostaglandins; 1981 Feb; 21(2):207-15. PubMed ID: 7221011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of labor with anencephalic fetus.
    Osathanondh R; Donnenfeld AE; Frigoletto FD; Driscoll SG; Ryan KJ
    Obstet Gynecol; 1980 Nov; 56(5):655-7. PubMed ID: 7432739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2.
    Liggins GC
    Prostaglandins; 1979 Jul; 18(1):167-72. PubMed ID: 392623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandins: an alternative concept for induction of labor.
    Shepherd JH; Knuppel RA
    South Med J; 1980 Nov; 73(11):1476-7. PubMed ID: 7444512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simpler approach to labor induction using lipid-based prostaglandin E2 vaginal suppository.
    MacKenzie IZ; Bradley S; Embrey MP
    Am J Obstet Gynecol; 1981 Sep; 141(2):158-62. PubMed ID: 6945046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alpha-fetoprotein, HPL, ostriol and SP1 concentrations in prostaglandin-induced mid-trimester abortions (author's transl)].
    Cornely M; Schumann K; Völker W; Weitzel H
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):446-51. PubMed ID: 78872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
    Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y
    Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reflections about the obstetric attitude towards anencephalic fetuses].
    Sedano L M; Sedano M R; Sedano R; Rodríguez A JG; Aedo M S
    Rev Med Chil; 2008 Jun; 136(6):789-92. PubMed ID: 18769838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 vaginal suppository as an early second trimester abortifacient.
    Bolognese RJ; Corson SL
    Obstet Gynecol; 1974 Jan; 43(1):104-8. PubMed ID: 4808950
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
    Sidhu MS; Kent DR
    Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.